Mednax Inc (MD) - Financial and Strategic SWOT Analysis Review

May 2021 | 69 pages | ID: M6F2D90153DEN
GlobalData

Abstracts

Mednax Inc (MD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Mednax Inc (Mednax) is a provider of physician services. The company offers a wide range of neonatal, maternal-fetal, paediatric cardiology and sub-specialty services. It also offers paediatric subspecialty care services such as inpatient care to ill children and services for the treatment of children’s ear, nose, throat, neck, urinary and genital problems through its paediatric intensivists, hospitalists, surgeons, urologists, ENT physicians, ophthalmologists and advanced nurse practitioners. The company through its affiliated professional corporations has presence in the US and in Puerto Rico. Mednax is headquartered in Sunrise, Florida, the US.

Mednax Inc Key Recent Developments

May 07,2021: Mednax Reports First Quarter Results
Mar 16,2021: Mednax expands presence in Texas through affiliation with eight-clinic pediatric urgent care practice
Feb 18,2021: Mednax - Reports fourth quarter results
Nov 06,2020: Mednax reports third quarter results for 2020
Sep 29,2020: MEDNAX: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Mednax Inc - Key Facts
Mednax Inc - Key Employees
Mednax Inc - Key Employee Biographies
Mednax Inc - Major Products and Services
Mednax Inc - History
Mednax Inc - Company Statement
Mednax Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Mednax Inc - Business Description
Other Break-up: Hospital Contract Administration Fee
Performance
Other Break-up: Net Patient Service Revenue
Performance
Other Break-up: Other Revenue
Performance
Mednax Inc - Corporate Strategy
Mednax Inc - SWOT Analysis
SWOT Analysis - Overview
Mednax Inc - Strengths
Mednax Inc - Weaknesses
Mednax Inc - Opportunities
Mednax Inc - Threats
Mednax Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Mednax Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 07, 2021: Mednax Reports First Quarter Results
Mar 16, 2021: Mednax expands presence in Texas through affiliation with eight-clinic pediatric urgent care practice
Feb 18, 2021: Mednax - Reports fourth quarter results
Nov 06, 2020: Mednax reports third quarter results for 2020
Sep 29, 2020: MEDNAX: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Aug 25, 2020: MEDNAX announces financial leadership transition
Jul 30, 2020: MEDNAX reports second quarter results
Jul 13, 2020: MEDNAX announces leadership and board transitions
Jun 05, 2020: MEDNAX announces significant progress in strategic transformation
May 07, 2020: MEDNAX reports first quarter results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Mednax Inc, Key Facts
Mednax Inc, Key Employees
Mednax Inc, Key Employee Biographies
Mednax Inc, Major Products and Services
Mednax Inc, History
Mednax Inc, Subsidiaries
Mednax Inc, Key Competitors
Mednax Inc, Ratios based on current share price
Mednax Inc, Annual Ratios
Mednax Inc, Annual Ratios (Cont...1)
Mednax Inc, Interim Ratios
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Mednax Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Mednax Inc, Performance Chart (2016 - 2020)
Mednax Inc, Ratio Charts
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mednax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021